
Open-label data show sustained seizure reduction, stable safety, and improved quality of life in LGS treated with fenfluramine.

Amelie Lothe, PhD, is Global Medical Community Head for Rare Epilepsies at UCB.

Open-label data show sustained seizure reduction, stable safety, and improved quality of life in LGS treated with fenfluramine.